丙泊酚与单次推注及滴定咪达唑仑用于门诊结肠镜检查镇静的比较:一项前瞻性随机双盲研究
该前瞻性随机双盲研究将267例门诊结肠镜检查患者随机分为丙泊酚组、单次推注咪达唑仑组和滴定咪达唑仑组(每组89例),比较操作总时间、诱导时间、恢复时间、离院时间、患者满意度及不良事件。丙泊酚组上述时间指标均短于两个咪达唑仑组,患者满意度更高,不良事件组间无显著差异。
要点
- 丙泊酚组操作总时间、诱导时间、恢复时间和离院时间均短于单次推注及滴定咪达唑仑组。
- 丙泊酚组患者满意度评分高于单次推注及滴定咪达唑仑联合哌替啶组。
- 三组不良事件发生率无显著差异。
核心结论
- 在门诊结肠镜检查中,丙泊酚在内镜中心效率和患者满意度方面优于单次推注或滴定咪达唑仑。
研究设计与样本
- 前瞻性随机双盲研究,共纳入267例门诊结肠镜检查患者,随机分为丙泊酚组、单次推注咪达唑仑组和滴定咪达唑仑组,每组89例。
主要发现
- 丙泊酚组操作总时间为39.5分钟,单次推注咪达唑仑组为59.4分钟,滴定咪达唑仑组为58.1分钟(P < .001)。
- 丙泊酚组诱导时间为4.6分钟,单次推注咪达唑仑组为6.3分钟,滴定咪达唑仑组为7.6分钟(P < .001)。
- 丙泊酚组恢复时间为11.5分钟,单次推注咪达唑仑组为29.5分钟,滴定咪达唑仑组为29.2分钟(P < .001)。
- 丙泊酚组离院时间为20.6分钟,单次推注咪达唑仑组为34.9分钟,滴定咪达唑仑组为34.7分钟(P < .001)。
- 丙泊酚组满意度评分为9.9,单次推注咪达唑仑联合哌替啶组为9.6,滴定咪达唑仑联合哌替啶组为9.6(P = .007);丙泊酚组另一满意度评分为4.9,单次推注咪达唑仑联合哌替啶组为4.7,滴定咪达唑仑联合哌替啶组为4.8(P = .008)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The safest and most efficient method of sedation for outpatient colonoscopy remains unclear. This study aimed to compare the efficiency and safety of bolus administration of midazolam compared with titrated administration and propofol administration for patients undergoing outpatient colonoscopy. METHODS: We randomly divided patients undergoing colonoscopy into the propofol group, bolus midazolam group, and titrated midazolam group. We compared total procedure time, induction time, recovery time, and discharge time among the 3 groups. We also compared patient satisfaction and the incidence of adverse events. RESULTS: In total, 267 patients (89 in each study group) were enrolled during the study period. Patients in the propofol group had a shorter total procedure time (39.5 vs 59.4 vs 58.1 minutes; P < .001), induction time (4.6 vs 6.3 vs 7.6 minutes; P < .001), recovery time (11.5 vs 29.5 vs 29.2 minutes; P < .001), and discharge time (20.6 vs 34.9 vs 34.7 minutes; P < .001) than patients in the bolus midazolam group and titrated midazolam group. Patients in the propofol group reported higher degrees of satisfaction than patients in the bolus or titrated midazolam plus meperidine groups (9.9 vs 9.6 vs 9.6 [P = .007] and 4.9 vs 4.7 vs 4.8 [P = .008], respectively). Adverse events were not significantly different between groups. CONCLUSIONS: In this randomized trial, propofol was superior to bolus or titrated midazolam in terms of endoscopy unit efficiency and patient satisfaction during outpatient colonoscopy. (Clinical trial registration number: KCT0002805.).
引用
- Kim DB, Kim JS, Huh CW, et al. Propofol compared with bolus and titrated midazolam for sedation in outpatient colonoscopy: a prospective randomized double-blind study. Gastrointest Endosc. 2020. PMID: 32504701. doi:10.1016/j.gie.2020.05.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。